Document Detail


ACE inhibitors versus diuretics: ALLHAT versus ANBP2.
MedLine Citation:
PMID:  12740004     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
The ALLHAT (The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial) trial enrolled hypertensive patients with at least one additional risk factor for coronary heart disease (CHD) to a comparison of the diuretic chlorthalidone, the calcium channel blocker, amlodipine, and the angiotensin-converting enzyme (ACE) inhibitor, lisinopril. Throughout the study, chlorthalidone decreased the systolic blood pressure to a slightly, but significantly greater extent (0.8-3.1 mmHg) than amlodipine or lisinopril. No significance differences were reported for amlodipine versus chlorthalidone or lisinopril versus chlorthalidone on the primary outcome of combined incidence of fatal CHD and nonfatal myocardial infarction. The findings of ALLHAT support the use of thiazide-type diuretics as first choice pharmacological therapy in at risk patients with hypertension. ANBP2 (The Second Australian National Blood Pressure Study) was also a comparison between diuretics (hydrochlorothiazide) and ACE inhibitors (enalapril) but was performed in older hypertensives that had few previous cardiovascular events. Diastolic blood pressure reduction was similar in both groups at all times. The risk of the primary outcome of all cardiovascular events or death from any cause was 11% lower in the ACE group than the diuretic group and the benefit was predominantly in men. Thus, ANBP2 suggests that in relatively healthy elderly hypertensive patients, ACE inhibitors should be preferred to diuretics.
Authors:
Sheila A Doggrell
Related Documents :
1822264 - Effects of the converting enzyme inhibitor trandolapril on short-term variability of bl...
6198274 - Converting-enzyme inhibition corrects the altered adrenal response to angiotensin ii in...
3333524 - Atenolol improves blood pressure control in patients taking captopril and frusemide.
7028334 - Immediate hemodynamic response to sq 14225 (captopril) in hypertensive and normotensive...
23628204 - Shape-anisotropic particles at curved fluid interfaces and role of laplace pressure: a ...
17496464 - Comparison of noninvasive oscillometric and intra-arterial blood pressure measurements ...
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  4     ISSN:  1465-6566     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-05-12     Completed Date:  2003-07-22     Revised Date:  2003-11-04    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  825-8     Citation Subset:  -    
Affiliation:
School of Biomedical Sciences, The University of Queensland, QLD 4072, Australia. s_doggrell@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections
Comment On:
JAMA. 2002 Dec 18;288(23):2981-97   [PMID:  12479763 ]
N Engl J Med. 2003 Feb 13;348(7):583-92   [PMID:  12584366 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Caspofungin: first approved agent in a new class of antifungals.
Next Document:  Evaluation of inducible promoters on the secretion of a ZZ-proinsulin fusion protein in Escherichia ...